Stem cells join forces with CAR-T in quest to beat relapsed blood cancers

NCT ID NCT05887167

First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 29 times

Summary

This early-phase study tests whether collecting a patient's own blood stem cells and giving them alongside CAR-T cell therapy is safe and doable for people with blood cancers that have come back or not responded to treatment. About 20 adults with cancers like lymphoma, leukemia, or multiple myeloma will take part. The main goals are to see if enough stem cells can be collected and to check for side effects like cytokine release syndrome and nerve problems in the first two months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cedars-Sinai Medical Center

    RECRUITING

    Los Angeles, California, 90048, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.